Magnesium deficiency induces an hyperalgesia reversed by the NMDA receptor antagonist MK801

NeuroReport

Volumn 8, Issue 6, 1997, Pages 1383-1386

  Dubray, C ^a   Alloui, A ^a   Bardin, L ^a   Rock, E ^b   Mazur, A ^b   Rayssiguier, Y ^b   Eschalier, A ^a   Lavarenne, J ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CEMAGREF   (France)

Author keywords

Dizocilpine; Hyperalgesia; Magnesium deficient rats; MK801; NMDA receptor antagonist

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; HYPOMAGNESEMIA; INFLAMMATORY CELL; ION TRANSPORT; MAGNESIUM DEFICIENCY; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN; STIMULUS RESPONSE;

EID: 0030904746     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199704140-00013     Document Type: Article

References (25)

1. Rayssiguier Y, Mazur A, Gueux E et al. Magnesium deficiency affects lipid metabolism and atherosclerosis process by a mechanism inflammation and oxidative stress. In: Halpern MJ and Durlach J, eds. Current Research in Magnesium, John Libbey Co., 1996: 251-255.
2. Weglicki WB and Phillips TM. Am J Physiol 263, R734-R737 (1992).
3. Lembeck F and Holzer P. Naunyn-Schmiedeberg's Arch Pharmacol 310, 175-183 (1979).
4. Barber. Eur J Pharmacol 236, 113-120 (1993).
5. Millan MJ and Seguin L. Eur J Pharmacol 238, 445-447 (1993).
6. Coderre TJ and Van Empel I. Pain 59, 345-352 (1994).
7. Yamamoto T, Shimoyama N and Misuguchi T. Anesthesiology 78, 124-133 (1993).
8. Sluka KA and Westlund KN. Pain 59, 95-100 (1994).
9. Ren K, Hylden JLK, Williams GM et al. Pain 50, 331-344 (1992).
10. Yamamoto T and Yaksh TL. Pain 49, 121-128 (1993).
11. Davar G, Hama A, Deykin A et al. Brain Res 553, 327-330 (1991).
12. Garrison CJ, Dougherty PM and Carlton SM. Brain Res 607, 205-214 (1993).
13. Paoletti P, Neyton J and Asher P. Neurology 15, 1109-1120 (1995).
14. Wang LY and McDonald JF. J Physiol (Lond) 486, 83-95 (1995).
15. Traub RD, Jefferys JGR and Whittington MA. J Physiol 478, 379-393 (1994).
16. Zimmermann M. Pain 16, 109-110 (1983).
17. Randall LO and Selitto JJ. Arch Int Pharmacodynam 61, 409-419 (1957).
18. Xiao WH and Bennett GJ. Brain Res 666, 168-172 (1994).
19. Feria M, Abad F, Sanchez A et al. Pain 53, 287-293 (1993).
20. Kayser V. and Guilbaud G. Pain 28, 99-107 (1987).
21. Calvino B, Crepon-Bernard MO and Lebras D. Behav Brain Res 24, 11-29 (1987).
22. Attal N, Jazat F, Kayser V et al. Pain 41, 235-251 (1990).
23. Bennet GJ and Xie YK. Pain 33, 87-107 (1988).
24. Courteix C, Eschalier A and Lavarenne J. Pain 53, 81-88 (1993).
25. Smith GD, Harisson SM and Birch PJ. Neurosci Lett 1 92, 33-36 (1995).